Poland· PL-100089965

Slow-Mag B6

A pyridoxine (vit b6) product containing magnesii chloridum hexahydricum + pyridoxini hydrochloridum, registered in Poland by ETHIFARM Sp. z o.o. Spółka Komandytowa. The same ATC class is registered in 9 of our 19 countries.

ATC A11HA02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedSlow-Mag B6ATCA11HA02REGISTER NO.PL-100089965PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Pyridoxine (vit b6) is registered in 9 of 19 countries.

Countries holding a registration under ATC A11HA02 (pyridoxine (vit b6)), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose

Pyridoxine (vit b6) · ATC A11HA02

9 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pyridoxine (vit b6) costs, country by country.

Normalised to the WHO defined daily dose (0.16 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Pyridoxine (vit b6) · price per daily dose (0.16 g)

USD · FX 28 Sept 2026

  • CH Switzerland$0.40
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Magnesii chloridum hexahydricum + Pyridoxini hydrochloridum
Manufacturer
ETHIFARM Sp. z o.o. Spółka Komandytowa
Country
Poland (PL)
ATC code
A11HA02
ATC class
Pyridoxine (vit B6)
Defined daily dose
0.16 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909990448418
  • gtin
    05903240495450

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

16 interactions on record for pyridoxine (vit b6).

Graded by severity as the source publishes them — 7 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Pyridoxine (vit b6) · interactions on record

16 records

  • 7 moderate
  • 9 minor

Most severe, free to view

  • AltretamineL01XX03moderate
  • PhenobarbitalN03AA02moderate
  • PhenytoinN03AB02moderate
  • LevodopaN04BA01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pyridoxine (vit b6) in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pyridoxine (vit b6) products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Bulgaria · Магне B6
  • Czechia · Magne B6
  • Estonia · Magne B6
  • France · Magne B6, Magnesium/Vitamine B6 Biogaran Conseil
  • Greece · Evrima-B6
  • Hungary · Magne B6, Magne B6 Forte
  • Lithuania · Magne B6
  • Latvia · Magne B6, Magne B6 Premium
  • Malta · Magnevie B6
  • Romania · Magne B6, Magne B6 Forte
  • Slovakia · Magne B6

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ff0aeb38-191d-455e-a9d9-c6e09c857592
GET /v1/drugs/ff0aeb38-191d-455e-a9d9-c6e09c857592?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki dojelitowe",
  "source": "urpl",
  "strength": "535 mg + 5 mg",
  "packaging": "05909990448418 ¦ OTC ¦ 14490\n50 tabl. w pojemniku\n05903240495450 ¦ OTC ¦ 160181\n50 tabl. w blistrze",
  "substance": "Magnesii chloridum 0.535 g + Pyridoxini hydrochloridum (Vitaminum B6) 0.005 g",
  "common_name": "Magnesii chloridum hexahydricum + Pyridoxini hydrochloridum",
  "pl_product_id": "100089965",
  "pozwolenie_nr": "04484",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about pyridoxine (vit b6).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.